Upcoming Events

There are no upcoming events available at this time.

Past Events

Jun 29, 2021
Presentation details to be shared at a later date.
Jun 17, 2021

Management will be available for 1x1 meetings throughout the day. There is no presentation/webcast associated with this event.

 

Jun 9, 2021

Galecto will host a key opinion leader event to discuss the current treatment landscape and unmet clinical need for myelofibrosis, as well as the potential for GB2064, Galecto’s LOXL2 inhibitor that is expected to enter a phase 2 trial in the current quarter.

Jun 3, 2021 8:30 AM EDT
May 12, 2021 8:00 AM EDT
Mar 30, 2021 2:00 PM EDT
Feb 24, 2021 9:20 AM EST
Jan 7, 2021 10:00 AM EST
Panel titled: EU Companies IPO-ing in the U.S.
Jan 7, 2021 8:00 AM EST
Panel titled: Separating the Wheat from the Chaff: Most Promising Novel Oncology Targets in Development